Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Anorexia Nervosa
NCT03414112Phase 1Completed
- Sponsor
- University of Minnesota
- Start
- Sep 2018
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in anorexia nervosa (AN) (2 arms), sponsored by University of Minnesota. Primary endpoints: Test meal and fMRI measures. Started Sep 2018; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NCT03414112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03414112.